Hospira's Retacrit wins positive opinion for sc administration in renal patients
This article was originally published in Scrip
Executive Summary
The EU's CHMP has issued a positive opinion on Hospira's biosimilar Retacrit (epoetin zeta) for subcutaneous use in renal anaemia.